Boehringer ingelheim

Index
Globenewswire

SPEVIGO® Approved for Expanded Indications in China and the US

Globenewswire

Survodutide Phase II Trial Shows 83% of Adults Treated Achieved Groundbreaking Results in Liver Disease Due to MASH, with Significant Improvements in Fibrosis

Globenewswire

New Collaboration Between Boehringer Ingelheim and Sleip Leverages AI-technology to help Detect Lameness in Horses

Globenewswire

Boehringer Expands Production Site in Greece for New Medicine